Multidrug-resistant Acinetobacter: Risk factors and outcomes in veterans with spinal cord injuries and disorders

被引:13
作者
Ramanathan, Swetha [1 ]
Suda, Katie J. [1 ,2 ]
Fitzpatrick, Margaret A. [1 ,3 ]
Poggensee, Linda [1 ]
LaVela, Sherri L. [1 ,4 ]
Burns, Stephen P. [5 ,6 ]
Evans, Charlesnika T. [1 ,7 ,8 ]
机构
[1] Edward Hines Jr VA Hosp, Dept Vet Affairs, Ctr Innovat Complex Chron Healthcare, Hines, IL 60141 USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
[3] Loyola Univ, Stritch Sch Med, Dept Internal Med, Chicago, IL 60611 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA
[5] VA Puget Sound Hlth Care Syst, Dept Vet Affairs, Spinal Cord Injury Serv, Seattle, WA USA
[6] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA
[7] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Dept Prevent Med, Chicago, IL 60611 USA
[8] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Ctr Hlth Care Studies, Chicago, IL 60611 USA
关键词
Spinal cord injury; Multidrug resistance; Acinetobacter; Epidemiology; Risk factors; 30-day mortality; Veterans Affairs; CLINICAL-OUTCOMES; BAUMANNII; INFECTIONS; EPIDEMIOLOGY; ORGANISMS; COMPLEX; DRUG;
D O I
10.1016/j.ajic.2017.06.016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Multidrug-resistant (MDR) Acinetobacter is a growing concern and has been identified as a serious threat by the Centers for Disease Control and Prevention. However, there is little information on MDR Acinetobacter in individuals with spinal cord injuries and disorders (SCI/Ds). Therefore, the objective of this study was to identify risk factors for, and assess outcomes of, MDR Acinetobacter in veterans with SCI/Ds. Methods: This was a retrospective cohort study from January 1, 2012-December 31, 2013, using national Veterans Affairs medical encounter and microbiology data. Results: A total of 773 Acinetobacter cultures were identified in 571 patients, of which 58.9% were MDR. Inpatient culture, sputum and other specimen type, receipt of antibiotics within 90 days before culture date, and pressure ulcers were identified as independent predictors of MDR Acinetobacter. Highest odds of MDR Acinetobacter were seen with previous antibiotic use (odds ratio, 7.27; 95% confidence interval, 2.59-20.54). Thirty-day mortality was 5.3% in this study. Multidrug resistance, previous mechanical ventilation 90 days before the culture, and cancer were all independent risk factors for 30-day mortality. Conclusions: There should be increased efforts to highlight the importance of antimicrobial stewardship to improve infection control to help limit spread of Acinetobacter in health care settings. Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.
引用
收藏
页码:1183 / 1189
页数:7
相关论文
共 50 条
[41]   Emergency department utilization in Veterans with spinal cord injuries & disorders [J].
Rech, Megan A. ;
Sippel, Jennifer L. ;
Huo, Zhiping ;
Willenberg, Rafer ;
Stroupe, Kevin ;
Smith, Bridget M. .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2024, 84 :50-55
[42]   Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates [J].
Al-Lawama, Manar ;
Aljbour, Haytham ;
Tanash, Asma ;
Badran, Eman .
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2016, 15
[43]   Recent insights on phage therapy against multidrug-resistant Acinetobacter baumannii [J].
Elshamy, Ann A. ;
Kamal, Sandra K. ;
Mahmoud, Mariam T. ;
Elhasany, Aya M. ;
Shady, Aya A. ;
Mohamed, Sherok A. ;
Abd-Elmaaboud, Hasna A. ;
El-Awady, Nour E. ;
Mohamed, Rana A. ;
El-Mirghany, Sara A. ;
El-Hady, Sarraa W. ;
Abd-ElRahman, Mohamed M. ;
Aboshanab, Khaled M. .
AMB EXPRESS, 2025, 15 (01)
[44]   Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis [J].
Patel, Jean A. ;
Pacheco, Susan M. ;
Postelnick, Michael ;
Sutton, Sarah .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (16) :1527-1531
[45]   Multidrug-Resistant Acinetobacter Baumannii: A Major Threat Worldwide [J].
Savov, E. ;
Mihaylova, G. ;
Borisova, M. ;
Stoeva, T. ;
Kjoseva, E. ;
Trifonova, A. .
COUNTERACTION TO CHEMICAL AND BIOLOGICAL TERRORISM IN EAST EUROPEAN COUNTRIES, 2009, :213-+
[46]   Multidrug-resistant Acinetobacter baumannii outbreak: an investigation of the possible routes of transmission [J].
Cristina, M. L. ;
Spagnolo, A. M. ;
Cenderello, N. ;
Fabbri, P. ;
Sartini, M. ;
Ottria, G. ;
Orlando, P. .
PUBLIC HEALTH, 2013, 127 (04) :386-391
[47]   In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii [J].
Abdul-Mutakabbir, Jacinda C. ;
Nguyen, Logan ;
Maassen, Philip T. ;
Stamper, Kyle C. ;
Kebriaei, Razieh ;
Kaye, Keith S. ;
Castanheira, Mariana ;
Rybak, Michael J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (09)
[48]   Multidrug-Resistant Acinetobacter baumannii in Veterinary Clinics, Germany [J].
Zordan, Sabrina ;
Prenger-Berninghoff, Ellen ;
Weiss, Reinhard ;
van der Reijden, Tanny ;
van den Broek, Peterhans ;
Baljer, Georg ;
Dijkshoorn, Lenie .
EMERGING INFECTIOUS DISEASES, 2011, 17 (09) :1751-1754
[49]   Microbiological features and risk factors for acquiring multidrug-resistant Acinetobacter baumannii bacteremia in pediatric patients. Case-control study [J].
Ruvinsky, Silvina ;
Fiorilli, Graciela ;
Perez, M. Guadalupe ;
Motto, Eduardo ;
Cambaceres, Carlos ;
Mannino, Leonardo ;
Lopardo, Horacio ;
Bologna, Rosa .
REVISTA CHILENA DE INFECTOLOGIA, 2015, 32 (01) :19-24
[50]   Multidrug-resistant tuberculosis: Epidemiology and risk factors [J].
Fourati, S. Smaoui ;
Mzid, H. ;
Marouane, C. ;
Kammoun, S. ;
Messadi-Akrout, F. .
REVUE DE PNEUMOLOGIE CLINIQUE, 2015, 71 (04) :233-241